Jianchun Zhao

443 total citations
21 papers, 386 citations indexed

About

Jianchun Zhao is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Jianchun Zhao has authored 21 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Pharmacology. Recurrent topics in Jianchun Zhao's work include Cancer therapeutics and mechanisms (6 papers), Chemical Reactions and Isotopes (4 papers) and Cancer Treatment and Pharmacology (3 papers). Jianchun Zhao is often cited by papers focused on Cancer therapeutics and mechanisms (6 papers), Chemical Reactions and Isotopes (4 papers) and Cancer Treatment and Pharmacology (3 papers). Jianchun Zhao collaborates with scholars based in China, United States and Japan. Jianchun Zhao's co-authors include Bin‐Gui Wang, James B. Gloer, Nai‐Yun Ji, Wenbao Li, Feng Li, Mengyan Deng, Shixiao Wang, Huashi Guan, Yanyan Chu and Riko Ozao and has published in prestigious journals such as Chemical Reviews, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Jianchun Zhao

19 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianchun Zhao China 10 155 117 65 64 55 21 386
Charles Pathirana United States 14 305 2.0× 251 2.1× 153 2.4× 34 0.5× 173 3.1× 36 665
Gregory A. Fechner Australia 14 210 1.4× 220 1.9× 167 2.6× 36 0.6× 108 2.0× 23 509
J.‐D. FOURNERON France 11 102 0.7× 143 1.2× 65 1.0× 35 0.5× 66 1.2× 17 348
F.-X. Garneau Canada 11 113 0.7× 90 0.8× 36 0.6× 62 1.0× 57 1.0× 17 318
Cun-Heng He United States 13 270 1.7× 152 1.3× 115 1.8× 21 0.3× 93 1.7× 21 566
David L. Burgoyne Canada 13 176 1.1× 201 1.7× 186 2.9× 20 0.3× 143 2.6× 15 513
Eric R. O. Siwu Japan 13 251 1.6× 262 2.2× 91 1.4× 18 0.3× 81 1.5× 18 475
Tara P. Pitts United States 15 337 2.2× 168 1.4× 280 4.3× 17 0.3× 205 3.7× 19 641
Chisato Tode Japan 11 92 0.6× 128 1.1× 42 0.6× 14 0.2× 45 0.8× 38 340
Pallavi Sharma United Kingdom 17 497 3.2× 260 2.2× 70 1.1× 12 0.2× 57 1.0× 33 722

Countries citing papers authored by Jianchun Zhao

Since Specialization
Citations

This map shows the geographic impact of Jianchun Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianchun Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianchun Zhao more than expected).

Fields of papers citing papers by Jianchun Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianchun Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianchun Zhao. The network helps show where Jianchun Zhao may publish in the future.

Co-authorship network of co-authors of Jianchun Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Jianchun Zhao. A scholar is included among the top collaborators of Jianchun Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianchun Zhao. Jianchun Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Liang, Zhongqiang Li, Yuxin Chen, et al.. (2025). Design, synthesis, and anti-cancer evaluation of the novel conjugate of gemcitabine's ProTide prodrug based on CD13. Bioorganic Chemistry. 157. 108293–108293. 1 indexed citations
2.
Li, Wenjia, Fuqiang Du, Jianchun Zhao, et al.. (2024). Copper-cyclodextrin metal-organic framework as a green catalyst for the thermal decomposition of nitrocellulose. Polymer Degradation and Stability. 229. 110958–110958. 3 indexed citations
3.
4.
Li, Zhuoyue, Chao Huang, Jinyu Liu, et al.. (2023). Discovery of Novel 2,3-Dihydro-1H-indene-5-sulfonamide NLRP3 Inflammasome Inhibitors Targeting Colon as a Potential Therapy for Colitis. Journal of Medicinal Chemistry. 66(23). 16141–16167. 7 indexed citations
5.
6.
Zhao, Jianchun, et al.. (2022). Design, synthesis, and biological evaluation of catalpalactone and its analogs. Medicinal Chemistry Research. 31(5). 794–804. 1 indexed citations
7.
Chen, Dan, et al.. (2021). Development and validation of LC–MS/MS method for amlexanox in rat plasma and its application in preclinical pharmacokinetics. Biomedical Chromatography. 36(3). e5288–e5288. 1 indexed citations
8.
Zhang, Liang, et al.. (2020). Design, synthesis, and biological evaluation of novel stachydrine derivatives as potent neuroprotective agents for cerebral ischemic stroke. Naunyn-Schmiedeberg s Archives of Pharmacology. 393(12). 2529–2542. 9 indexed citations
9.
Li, Feifei, et al.. (2020). Structure-based design and synthesis of novel furan-diketopiperazine-type derivatives as potent microtubule inhibitors for treating cancer. Bioorganic & Medicinal Chemistry. 28(10). 115435–115435. 19 indexed citations
10.
Zang, Ruochen, Feifei Li, Jianchun Zhao, et al.. (2019). Combination of a novel microtubule inhibitor MBRI-001 and gemcitabine synergistically induces cell apoptosis by increasing DNA damage in pancreatic cancer cell lines. Investigational New Drugs. 38(5). 1207–1217. 5 indexed citations
11.
Yang, Chong, Jianchun Zhao, Zhiyu Song, et al.. (2019). Development of M10, myricetin-3-O-β-d-lactose sodium salt, a derivative of myricetin as a potent agent of anti-chronic colonic inflammation. European Journal of Medicinal Chemistry. 174. 9–15. 20 indexed citations
12.
Zhang, Liang, et al.. (2018). Synthesis of deuterium-enriched sorafenib derivatives and evaluation of their biological activities. Molecular Diversity. 23(2). 341–350. 18 indexed citations
13.
Deng, Mengyan, Linna Li, Jianchun Zhao, Shoujun Yuan, & Wenbao Li. (2018). Antitumor activity of the microtubule inhibitor MBRI-001 against human hepatocellular carcinoma as monotherapy or in combination with sorafenib. Cancer Chemotherapy and Pharmacology. 81(5). 853–862. 12 indexed citations
14.
Zhao, Jianchun, et al.. (2018). In vitro and in vivo pharmacokinetic and pharmacodynamic study of MBRI-001, a deuterium-substituted plinabulin derivative as a potent anti-cancer agent. Bioorganic & Medicinal Chemistry. 26(16). 4687–4692. 9 indexed citations
15.
Chu, Yanyan, et al.. (2017). Rational drug design of indazole‐based diarylurea derivatives as anticancer agents. Chemical Biology & Drug Design. 90(4). 609–617. 20 indexed citations
16.
Wang, Shixiao, et al.. (2017). Development of MBRI-001, a deuterium-substituted plinabulin derivative as a potent anti-cancer agent. Bioorganic & Medicinal Chemistry Letters. 27(6). 1416–1419. 19 indexed citations
17.
Zhao, Jianchun, Xiao‐Ming Li, James B. Gloer, & Bin‐Gui Wang. (2014). First Total Syntheses and Antimicrobial Evaluation of Penicimonoterpene, a Marine-Derived Monoterpenoid, and Its Various Derivatives. Marine Drugs. 12(6). 3352–3370. 9 indexed citations
18.
Wang, Bin‐Gui, James B. Gloer, Nai‐Yun Ji, & Jianchun Zhao. (2013). Halogenated Organic Molecules of Rhodomelaceae Origin: Chemistry and Biology. Chemical Reviews. 113(5). 3632–3685. 196 indexed citations
19.
Sun, Li, et al.. (2009). Inhibitory study of two cephalosporins on E. coli by microcalorimetry. Journal of Thermal Analysis and Calorimetry. 100(2). 589–592. 26 indexed citations
20.
Xu, Fen, Lei Sun, Ping Chen, et al.. (2009). Studies on heat capacities and thermal analysis of Li–Mg–N–H hydrogen storage system. Journal of Thermal Analysis and Calorimetry. 100(2). 701–706. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles Pathirana Breakdown of academic impact, for papers by Gregory A. Fechner Breakdown of academic impact, for papers by J.‐D. FOURNERON Breakdown of academic impact, for papers by F.-X. Garneau Breakdown of academic impact, for papers by Cun-Heng He Breakdown of academic impact, for papers by David L. Burgoyne Breakdown of academic impact, for papers by Eric R. O. Siwu Breakdown of academic impact, for papers by Tara P. Pitts Breakdown of academic impact, for papers by Chisato Tode Breakdown of academic impact, for papers by Pallavi Sharma
Rankless by CCL
2026